Compare ADPT & GTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADPT | GTY |
|---|---|---|
| Founded | 2009 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.0B |
| IPO Year | 2019 | 1998 |
| Metric | ADPT | GTY |
|---|---|---|
| Price | $13.56 | $33.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | $17.78 | ★ $32.60 |
| AVG Volume (30 Days) | ★ 1.6M | 331.2K |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 5.92% |
| EPS Growth | ★ 63.89 | 8.00 |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $276,976,000.00 | $221,727,000.00 |
| Revenue This Year | $3.98 | $9.39 |
| Revenue Next Year | $22.72 | $7.83 |
| P/E Ratio | ★ N/A | $76.88 |
| Revenue Growth | ★ 54.77 | 9.02 |
| 52 Week Low | $8.50 | $25.39 |
| 52 Week High | $20.76 | $34.75 |
| Indicator | ADPT | GTY |
|---|---|---|
| Relative Strength Index (RSI) | 45.10 | 49.25 |
| Support Level | $12.22 | $32.56 |
| Resistance Level | $15.38 | $34.08 |
| Average True Range (ATR) | 0.79 | 0.64 |
| MACD | -0.02 | -0.08 |
| Stochastic Oscillator | 27.88 | 25.28 |
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.
Getty Realty Corp is a net lease real estate investment trust in the U.S.A, specializing in the acquisition, financing, and development of convenience, automotive, and other single-tenant retail real estate. The company's portfolio includes convenience stores, express tunnel car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, and collision), drive-thru quick service restaurants, and certain other freestanding retail properties. It generates maximum revenue in the form of rental income.